14-23118596-G-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001805.4(CEBPE):ā€‹c.496C>Gā€‹(p.Leu166Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,457,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 32)
Exomes š‘“: 0.0000014 ( 0 hom. )

Consequence

CEBPE
NM_001805.4 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.70
Variant links:
Genes affected
CEBPE (HGNC:1836): (CCAAT enhancer binding protein epsilon) The protein encoded by this gene is a bZIP transcription factor which can bind as a homodimer to certain DNA regulatory regions. It can also form heterodimers with the related protein CEBP-delta. The encoded protein may be essential for terminal differentiation and functional maturation of committed granulocyte progenitor cells. Mutations in this gene have been associated with Specific Granule Deficiency, a rare congenital disorder. Multiple variants of this gene have been described, but the full-length nature of only one has been determined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.22025129).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CEBPENM_001805.4 linkuse as main transcriptc.496C>G p.Leu166Val missense_variant 1/2 ENST00000206513.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CEBPEENST00000206513.6 linkuse as main transcriptc.496C>G p.Leu166Val missense_variant 1/21 NM_001805.4 P1
CEBPEENST00000696121.1 linkuse as main transcriptn.465C>G non_coding_transcript_exon_variant 2/3
CEBPEENST00000696122.1 linkuse as main transcriptn.242C>G non_coding_transcript_exon_variant 2/3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1457000
Hom.:
0
Cov.:
32
AF XY:
0.00000276
AC XY:
2
AN XY:
724976
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Specific granule deficiency Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeOct 20, 2018In summary, this variant has uncertain impact on CEBPE function. The available evidence is currently insufficient to determine its role in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with a CEBPE-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces leucine with valine at codon 166 of the CEBPE protein (p.Leu166Val). The leucine residue is highly conserved and there is a small physicochemical difference between leucine and valine. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.21
T
Eigen
Uncertain
0.21
Eigen_PC
Benign
0.18
FATHMM_MKL
Benign
0.71
D
LIST_S2
Benign
0.73
T
M_CAP
Benign
0.0085
T
MetaRNN
Benign
0.22
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
1.5
L
MutationTaster
Benign
0.81
D
PrimateAI
Uncertain
0.64
T
PROVEAN
Benign
-0.060
N
REVEL
Benign
0.082
Sift
Benign
0.20
T
Sift4G
Benign
0.26
T
Polyphen
0.99
D
Vest4
0.079
MutPred
0.29
Gain of catalytic residue at G163 (P = 0.0379);
MVP
0.39
MPC
0.59
ClinPred
0.57
D
GERP RS
2.3
Varity_R
0.054
gMVP
0.35

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1273577069; hg19: chr14-23587805; API